METABOLIC SYNDROME;

Abstract

Background: Metabolic syndrome and diabetes mellitus are the modifiable riskfactors of cardiovascular diseases that double the chance of illness when occur together. Littlework has been reported on the superlative criteria to diagnose metabolic syndrome amongdiabetics from the country. Therefore, the study was aimed to find the agreement betweenmetabolic syndrome diagnostic criteria among type 2 diabetics. Methods: The retrospectivedata of 373 known type 2 diabetics who had reported history of taking antidiabetic medicineswas analyzed. The new International Diabetes Federation definition, the World HealthOrganization criteria and the NCEP Adult Treatment Panel III criteria were used to diagnosemetabolic syndrome. Data was analyzed by using Statistical Package for Social Sciencesversion 21. Results: Mean age of 373 diabetics was 49±10 years. Participants included 36.5%males and 63.5% females. Mean BMI, WC and BP were high in females; while HDL-C waslow in males (p <0.05). The frequency of MS by ATP III, IDF and WHO criteria were 88.2%;87.4%; and 86.3%, respectively. Significant association was present between femininity, highersocioeconomic status and MS (p <0.05). ATP III criteria diagnosed the maximum number of MSfollowed by IDF and WHO criteria. The highest agreement was found between ATP III and IDFcriteria (k 0.487). More than 85.0% diabetics were diagnosed as true positive and true negativeon all three criteria. The disagreement between the studied criteria ranged from 5.1% to 8.0%.Conclusion: The ATP III, IDF and WHO criteria can equally be used to diagnose metabolicsyndrome among type 2 diabetics in the settings. However, ATP III and IDF criteria have anedge over WHO criteria. Increased rate of metabolic syndrome among diabetics have need ofserious attention to reduce the risk of cardiovascular events.